与组织等离子体激活剂一起报告的血管功能瘤:需要沟通布拉迪基宁和胰岛素介导机制
Anaïs Maurier1, Frédérique Beau-Salinas1, Bérenger Largeau1
1Department of Pharmacosurveillance, Pharmacovigilance Regional Center of Centre Val-de-Loire, University Hospital of Tours, 37000 Tours, France.
Therapie
|February 25, 2026
概括
大多数与重组组织等离子体激活剂 (rt-PA) 相关的血管腺 (AE) 病例都是布拉迪基宁介导的 (BK-AE). 早期识别和适当的布拉迪基宁向治疗对于管理这些不良事件至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 药物不良反应 药物不良反应
背景情况:
- 血管 (AE) 是一种严重的不良反应,具有明显的布拉迪基宁介导 (BK-AE) 和基因组介导 (Hi-AE) 机制.
- 复合组织等离子体激活剂 (rt-PA),包括阿尔特等离子体和特内克等离子体,已与AE相关,表明免疫过敏或布拉迪基尼路径.
研究的目的:
- 为了描述法国药监中心与rt-PA报告的AE病例.
- 优化与rt-PA治疗相关的BK-AE和Hi-AE的识别和管理.
主要方法:
- 分析到2023年11月30日用阿尔泰或基报告的AE病例.
- 根据临床表现,管理和过敏学检查,将AE分为BK-AE或Hi-AE.
主要成果:
- 分析了151个AE病例,107个被分类,其中98% (98/107) 被确定为BK-AE.
- 在98%的病例中,阿尔特普拉斯与此有关,主要是急性缺血性中风.
- 在68% (32/47) 的特定病例中,像伊卡蒂班特这样的布拉迪基宁向治疗是第一线治疗.
结论:
- 大多数与rt-PA相关的AE是BK-AE,主要与阿尔特等相关.
- rt-PA激活了基宁通路,导致了布拉迪基宁的形成.
- 临床医生需要意识到这种机制,以便及时和适当地治疗,因为它并不总是最初的方法.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:30Allergic Reactions: Anaphylaxis
77
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
77
02:06Allergic Reactions
32.7K
Overview
32.7K
01:16Vascular Spasm
4.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
01:19Hypersensitivity Reactions: Immune-Complex Reactions
64
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
64